Italian Researchers Find Fenretinide Cuts The Risk Of Second Breast Cancers In Young Women; Unsafe For Older Breast-Cancer Survivors
A 15-year follow-up of women in a breast cancer trial has found that fenretinide[1] – a drug related to vitamin A – significantly cuts the risk of a second breast cancer among younger patients.